miR-222 exerts negative regulation on insulin signaling pathway in 3T3-L1 adipocytes.
adipocytes
adipogenesis
insulin resistance
insulin signaling pathway
miR-222
Journal
BioFactors (Oxford, England)
ISSN: 1872-8081
Titre abrégé: Biofactors
Pays: Netherlands
ID NLM: 8807441
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
14
06
2022
accepted:
12
10
2022
medline:
14
4
2023
pubmed:
1
11
2022
entrez:
31
10
2022
Statut:
ppublish
Résumé
Increased miR-222 levels are associated with metabolic syndrome, insulin resistance, and diabetes. Moreover, rats fed an obesogenic diet during lactation have higher miR-222 content in breast milk and the offspring display greater body fat mass and impaired insulin sensitivity in adulthood. In order to investigate the molecular mechanisms involved and to dissect the specific effects of miR-222 on adipocytes, transfection with a mimic or an inhibitor of miR-222 has been conducted on 3T3-L1 preadipocytes. 3T3-L1 cells were transfected with either a mimic or an inhibitor of miR-222 and collected after 2 days (preadipocytes) or 8 days (mature adipocytes) for transcriptomic analysis. Results showed a relevant impact on pathways associated with insulin signaling, lipid metabolism and adipogenesis. Outcomes in key genes and proteins were further analyzed with quantitative reverse transcription polymerase chain reaction and Western Blotting, respectively, which displayed a general inhibition in important effectors of the identified routes under miR-222 mimic treatment in preadipocytes. Although to a lesser extent, this overall signature was maintained in differentiated adipocytes. Altogether, miR-222 exerts a direct effect in metabolic pathways of 3T3-L1 adipocytes that are relevant to adipocyte function, limiting adipogenesis and insulin signaling pathways, offering a mechanistic explanation for its reported association with metabolic diseases.
Substances chimiques
Insulin
0
MicroRNAs
0
MIRN222 microRNA, mouse
0
MIRN222 microRNA, rat
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
365-378Subventions
Organisme : Instituto de Salud Carlos III
ID : PI17/01614
Organisme : Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn)
Organisme : European Union
Informations de copyright
© 2022 The Authors. BioFactors published by Wiley Periodicals LLC on behalf of International Union of Biochemistry and Molecular Biology.
Références
Bartel DP. Metazoan MicroRNAs. Cell. 2018;173:20-51.
Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases. Clin Genet. 2008;74:307-15.
Li Y, Kowdley KV. MicroRNAs in common human diseases. Genom Proteom Bioinform. 2012;10:246-53.
Deiuliis JA. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond). 2016;40:88-101.
Ortega FJ, Mercader JM, Catalán V, Moreno-Navarrete JM, Pueyo N, Sabater M, et al. Targeting the circulating microRNA signature of obesity. Clin Chem. 2013;59:781-92.
Chartoumpekis DV, Zaravinos A, Ziros PG, Iskrenova RP, Psyrogiannis AI, Kyriazopoulou VE, et al. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One. 2012;7:34872.
Herrera BM, Lockstone HE, Taylor JM, Ria M, Barrett A, Collins S, et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia. 2010;53:1099-109.
Cui X, You L, Zhu L, Wang X, Zhou Y, Li Y, et al. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes. Metabolism. 2018;78:95-105.
Ortega FJ, Mercader JM, Moreno-Navarrete JM, Rovira O, Guerra E, Esteve E, et al. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care. 2014;37:1375-83.
Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733-41.
Xi Y, Jiang X, Li R, Chen M, Song W, Li X. The levels of human milk microRNAs and their association with maternal weight characteristics. Eur J Clin Nutr. 2016;70:445-9.
Zamanillo R, Sánchez J, Serra F, Palou A. Breast milk supply of microRNA associated with leptin and adiponectin is affected by maternal overweight/obesity and influences infancy BMI. Nutrients. 2019;11:2589.
Pomar CA, Castro H, Picó C, Serra F, Palou A, Sánchez J. Cafeteria diet consumption during lactation in rats, rather than obesity per Se, alters miR-222, miR-200a, and miR-26a levels in milk. Mol Nutr Food Res. 2019;63:1800928.
Munch EM, Harris RA, Mohammad M, Benham AL, Pejerrey SM, Showalter L, et al. Transcriptome profiling of microRNA by next-gen deep sequencing reveals known and novel miRNA species in the lipid fraction of human breast Milk. PLoS One. 2013;8:e50564.
Reynolds CM, Gray C, Li M, Segovia SA, Vickers MH. Early life nutrition and energy balance disorders in offspring in later life. Nutrients. 2015;7:8090-111.
Langley-Evans SC. Nutrition in early life and the programming of adult disease: a review. J Hum Nutr Diet. 2015;28:1-14.
Melnik BC, John SM, Schmitz G. Milk: an exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy? J Transl Med. 2014;12:43.
Zhou Q, Li M, Wang X, Li Q, Wang T, Zhu Q, et al. Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci. 2011;8:118-23.
Pomar CA, van Nes R, Sánchez J, Picó C, Keijer J, Palou A. Maternal consumption of a cafeteria diet during lactation in rats leads the offspring to a thin-outside-fat-inside phenotype. Int J Obes (Lond). 2017;41:1279-87.
Pomar CA, Castro H, Picó C, Palou A, Sánchez J. Maternal overfeeding during lactation impairs the metabolic response to fed/fasting changing conditions in the postweaning offspring. Mol Nutr Food Res. 2019;63:1900504.
Pomar CA, Picó C, Palou A, Sánchez J. Maternal consumption of a cafeteria diet during lactation leads to altered diet-induced thermogenesis in descendants after exposure to a Western diet in adulthood. Nutrients. 2022;14:1958.
Pomar CA, Serra F, Palou A, Sánchez J. Lower miR-26a levels in breastmilk affect gene expression in adipose tissue of offspring. FASEB J. 2021;35:e21924.
Hidalgo MR, Cubuk C, Amadoz A, Salavert F, Carbonell-Caballero J, Dopazo J. High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes. Oncotarget. 2017;8:5160-78.
Yang YF, Wang F, Xiao JJ, Song Y, Zhao YY, Cao Y, et al. MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27. Int J Clin Exp Med. 2014;7:893-902.
Chen Y, Wang X. MiRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127-31.
Qi R, Han X, Wang J, Qiu X, Wang Q, Yang F. MicroRNA-489-3p promotes adipogenesis by targeting the Postn gene in 3T3-L1 preadipocytes. Life Sci. 2021;278:119620.
Nunes ADC, Weigl M, Schneider A, Noureddine S, Yu L, Lahde C, et al. miR-146a-5p modulates cellular senescence and apoptosis in visceral adipose tissue of long-lived Ames dwarf mice and in cultured pre-adipocytes. GeroScience. 2022;44:503-18.
Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes. 2009;58:1050-7.
Softic S, Boucher J, Solheim MH, Fujisaka S, Haering MF, Homan EP, et al. Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD. Diabetes. 2016;65:2187-200.
Sasaki T, Kuroko M, Sekine S, Matsui S, Kikuchi O, Susanti VY, et al. Overexpression of insulin receptor partially improves obese and diabetic phenotypes in db/db mice. Endocr J. 2015;62:787-96.
Tang CY, Man XF, Guo Y, Tang HN, Tang J, Zhou CL, et al. IRS-2 partially compensates for the insulin signal defects in IRS-1−/− mice mediated by miR-33. Mol Cells. 2017;40:123-32.
Ono K, Igata M, Kondo T, Kitano S, Takaki Y, Hanatani S, et al. Identification of microRNA that represses IRS-1 expression in liver. PLoS One. 2018;13:e0191553.
Winnay JN, Solheim MH, Dirice E, Sakaguchi M, Noh HL, Kang HJ, et al. PI3-kinase mutation linked to insulin and growth factor resistance in vivo. J Clin Investig. 2016;126:1401-12.
Huang-Doran I, Tomlinson P, Payne F, Gast A, Sleigh A, et al. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations. JCI Insight. 2016;1:e88766.
Rancourt RC, Ott R, Schellong K, Melchior K, Ziska T, Henrich W, et al. Visceral adipose tissue alteration of PI3KR1 expression is associated with gestational diabetes but not promoter DNA methylation. Adipocyte. 2019;8:339-46.
Zhang Z, Liu H, Liu J. Akt activation: a potential strategy to ameliorate insulin resistance. Diabetes Res Clin Pract. 2019;156:107092.
Lu M, Wan M, Leavens KF, Chu Q, Monks BR, Fernandez S, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med. 2012;18:388-95.
Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol. 2005;25:2498-510.
Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Investig. 2013;123:2764-72.
Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch. 2020;472:1273-98.
Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436:356-62.
Stenbit AE, Tsao TS, Li J, Burcelin R, Geenen DL, Factor SM, et al. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med. 1997;3:1096-101.
Shepherd PR, Kahn BB. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. New Engl J Med. 1999;341:248-57.
Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell. 2002;110:489-500.
Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, et al. Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity. Diabetes. 2013;62:3697-708.
Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, et al. Identification of Cd36 (fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 1999;21:76-83.
Kuwasako T, Hirano KI, Sakai N, Ishigami M, Hiraoka H, Yakub MJ, et al. Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism. Diabetes Care. 2003;26:1647-8.
Weinstock PH, Levak-Frank S, Hudgins LC, Radner H, Friedman JM, Zechner R, et al. Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase. Proc Natl Acad Sci U S A. 1997;94:10261-6.
Semenkovich CF, Wims M, Noe L, Etienne J, Chan L. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J Biol Chem. 1989;264:9030-8.
Tamori Y, Masugi J, Nishino N, Kasuga M. Role of peroxisome proliferator-activated receptor-γ in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes. 2002;51:2045-55.
He W, Barak Y, Hevener A, Olson P, Liao D, le J, et al. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A. 2003;100:15712-7.
Eichhorn SW, Guo H, McGeary SE, Rodriguez-Mias RA, Shin C, Baek D, et al. MRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues. Mol Cell. 2014;56:104-15.
Hausser J, Syed AP, Selevsek N, Van Nimwegen E, Jaskiewicz L, et al. Timescales and bottlenecks in miRNA-dependent gene regulation. Mol Syst Biol. 2013;9:711.
Schwanhüusser B, Busse D, Li N, Dittmar G, Schuchhardt J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473:337-42.
Fuso A, Raia T, Orticello M, Lucarelli M. The complex interplay between DNA methylation and miRNAs in gene expression regulation. Biochimie. 2020;173:12-6.